Bristol-Myers Squibb Issues First Corporate Responsibility Report In China
This article was originally published in PharmAsia News
Executive Summary
U.S. biopharma giant Bristol-Myers Squibb has published its first corporate responsibility report in China after 30 years of in-country presence.